restore vision announces first in human clinical interim results for rv 001 a gpcr based optogenetic gene therapy

EPU_POLICY_REGULATORYSCIENCESOC_INNOVATIONWB_1614_NUTRITIONAL_PROGRAMS

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.